150 related articles for article (PubMed ID: 1002821)
1. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
Delitala G; Masala A; Alagna S; Devilla L; Lotti G
J Clin Endocrinol Metab; 1976 Dec; 43(6):1382-6. PubMed ID: 1002821
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
Chiodini PG; Liuzzi A; Muller EE; Botalla L; Cremascoli G; Oppizzi G; Verde G; Silvestrini F
J Clin Endocrinol Metab; 1976 Aug; 43(2):356-63. PubMed ID: 950367
[TBL] [Abstract][Full Text] [Related]
3. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
Delitala G
Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618
[TBL] [Abstract][Full Text] [Related]
4. Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154).
Agnati LF; Benfenati F; Frank G; Capelli M; Bernardi P; Calza L
Med Biol; 1981 Feb; 59(1):58-63. PubMed ID: 7266088
[TBL] [Abstract][Full Text] [Related]
5. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
Pontiroli AE; Castegnaro E; Vettaro MP; Viberti GC; Pozza G
Acta Endocrinol (Copenh); 1977 Jan; 84(1):36-44. PubMed ID: 318788
[No Abstract] [Full Text] [Related]
6. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
[TBL] [Abstract][Full Text] [Related]
7. Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa.
Pontiroli AE; Viberti GC; Tognetti A; Pozza G
Horm Metab Res; 1976 Mar; 8(2):106-8. PubMed ID: 1261961
[TBL] [Abstract][Full Text] [Related]
8. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
Hara I; Kataoka K; Tomita A; Takanohashi M; Nakane T; Kuwayama A; Kageyama N
Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):16-24. PubMed ID: 581754
[TBL] [Abstract][Full Text] [Related]
9. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
[TBL] [Abstract][Full Text] [Related]
10. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
11. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
Bohnet HG; Kato K; De Moll H
Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541
[TBL] [Abstract][Full Text] [Related]
12. Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.
Ishibashi M; Yamaji T; Kosaka K
J Clin Endocrinol Metab; 1978 Aug; 47(2):418-21. PubMed ID: 400720
[TBL] [Abstract][Full Text] [Related]
13. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
Krulich L; McCann SM; Mayfield MA
Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
15. Action of metergoline in suppressing prolactin release induced by mechanical breast emptying.
Delitala G; Lodico G; Masala A; Alagna S; Devilla L
J Clin Endocrinol Metab; 1977 Apr; 44(4):763-5. PubMed ID: 849985
[TBL] [Abstract][Full Text] [Related]
16. [Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
Felt V; Nedvídková J; Krejcík L; Hainer V
Cas Lek Cesk; 1977 May; 116(19):591-4. PubMed ID: 406999
[No Abstract] [Full Text] [Related]
17. Inhibition of prolactin release by metergoline administration in man.
Delitala G; Masala A; Alagna S; Devilla L; Rovasio PP
Biomedicine; 1977 Jan; 27(1):31-3. PubMed ID: 856312
[TBL] [Abstract][Full Text] [Related]
18. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.
Ferrari C; Caldara R; Rampini P; Telloli P; Romussi M; Bertazzoni A; Polloni G; Mattei A; Crosignani PG
Metabolism; 1978 Oct; 27(10):1499-504. PubMed ID: 692379
[TBL] [Abstract][Full Text] [Related]
20. Regulation of prolactin and growth hormone secretion. Site and mechanism of action of thyrotropin-releasing hormone, L-dopa and L-5-hydroxytryptophan in unanesthetized dogs.
Richards GE; Holland FJ; Aubert ML; Ganong WF; Kaplan SL; Grumbach MM
Neuroendocrinology; 1980; 30(3):139-43. PubMed ID: 6767993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
